Estimates Revisions Seres Therapeutics, Inc.
Stocks
MCRB
US81750R2013
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.570 USD | -2.35% |
|
+2.01% | -69.29% |
| 08-13 | Seres Therapeutics Files $300 Million Mixed Shelf | MT |
| 08-05 | Seres Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- MCRB Stock
- Consensus Seres Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
